External Source

Safety & Efficacy Of Cesnicabtagene Autoleucel (ari0002h) In R/r Multiple Myeloma

2022 5:35
Synopsis
Despite significant improvements in the treatment of relapsed/refractory (R/R) multiple myeloma, patient survival remains poor.
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.